Cardiomyopathy, Hypertrophic
"Cardiomyopathy, Hypertrophic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).
Descriptor ID |
D002312
|
MeSH Number(s) |
C14.280.238.100 C14.280.484.150.070.160
|
Concept/Terms |
Cardiomyopathy, Hypertrophic- Cardiomyopathy, Hypertrophic
- Cardiomyopathies, Hypertrophic
- Hypertrophic Cardiomyopathies
- Hypertrophic Cardiomyopathy
- Cardiomyopathy, Hypertrophic Obstructive
- Cardiomyopathies, Hypertrophic Obstructive
- Hypertrophic Obstructive Cardiomyopathies
- Hypertrophic Obstructive Cardiomyopathy
- Obstructive Cardiomyopathies, Hypertrophic
- Obstructive Cardiomyopathy, Hypertrophic
|
Below are MeSH descriptors whose meaning is more general than "Cardiomyopathy, Hypertrophic".
Below are MeSH descriptors whose meaning is more specific than "Cardiomyopathy, Hypertrophic".
This graph shows the total number of publications written about "Cardiomyopathy, Hypertrophic" by people in this website by year, and whether "Cardiomyopathy, Hypertrophic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 1 | 2 | 1995 | 2 | 0 | 2 | 1998 | 2 | 0 | 2 | 1999 | 3 | 2 | 5 | 2000 | 1 | 0 | 1 | 2001 | 2 | 1 | 3 | 2003 | 1 | 0 | 1 | 2004 | 3 | 0 | 3 | 2005 | 2 | 0 | 2 | 2006 | 3 | 1 | 4 | 2007 | 2 | 0 | 2 | 2008 | 1 | 1 | 2 | 2009 | 4 | 0 | 4 | 2010 | 1 | 1 | 2 | 2011 | 2 | 0 | 2 | 2012 | 4 | 0 | 4 | 2013 | 2 | 0 | 2 | 2014 | 2 | 0 | 2 | 2015 | 5 | 0 | 5 | 2016 | 5 | 1 | 6 | 2017 | 2 | 0 | 2 | 2018 | 4 | 0 | 4 | 2019 | 7 | 1 | 8 | 2020 | 3 | 2 | 5 | 2021 | 2 | 0 | 2 | 2022 | 4 | 0 | 4 | 2023 | 7 | 0 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Cardiomyopathy, Hypertrophic" by people in Profiles.
-
Vissing CR, Axelsson Raja A, Day SM, Russell MW, Zahka K, Lever HM, Pereira AC, Colan SD, Margossian R, Murphy AM, Canter C, Bach RG, Wheeler MT, Rossano JW, Owens AT, Benson L, Mestroni L, Taylor MRG, Patel AR, Wilmot I, Thrush P, Soslow JH, Becker JR, Seidman CE, Lakdawala NK, Cirino AL, McMurray JJV, MacRae CA, Solomon SD, Bundgaard H, Orav EJ, Ho CY. Cardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical Trial. JAMA Cardiol. 2023 11 01; 8(11):1083-1088.
-
Marshall M, Malik A, Shah M, Fish FA, Etheridge SP, Aziz PF, Russell MW, Tisma S, Pflaumer A, Sreeram N, Kubus P, Law IH, Kantoch MJ, Kertesz NJ, Strieper M, Erickson CC, Moore JP, Nakano SJ, Singh HR, Chang P, Cohen M, Fournier A, Ilina MV, Zimmermann F, Horndasch M, Li W, Batra AS, Liberman L, Hamilton R, Janson CM, Sanatani S, Zeltser I, McDaniel G, Blaufox AD, Garnreiter JM, Balaji S. Patterns of Electrocardiographic Abnormalities in Children with Hypertrophic Cardiomyopathy. Pediatr Cardiol. 2024 Dec; 45(8):1692-1701.
-
Kirmani S, Woodard PK, Shi L, Hamza TH, Canter CE, Colan SD, Pahl E, Towbin JA, Webber SA, Rossano JW, Everitt MD, Molina KM, Kantor PF, Jefferies JL, Feingold B, Addonizio LJ, Ware SM, Chung WK, Ballweg JA, Lee TM, Bansal N, Razoky H, Czachor J, Lunze FI, Marcus E, Commean P, Wilkinson JD, Lipshultz SE. Cardiac imaging and biomarkers for assessing myocardial fibrosis in children with hypertrophic cardiomyopathy. Am Heart J. 2023 10; 264:153-162.
-
Geddes GC, Parent JJ, Lander J, Jeewa A, Ware SM, Villa C, Chatfield KC, Weaver KN. MEK Inhibition Improves Cardiomyopathy in Costello Syndrome. J Am Coll Cardiol. 2023 04 11; 81(14):1439-1441.
-
Kim Y, Mastali M, Van Eyk JE, Orav EJ, Vissing CR, Day SM, Axelsson Raja A, Russell MW, Zahka K, Lever HM, Pereira AC, Murphy AM, Canter C, Bach RG, Wheeler MT, Rossano JW, Owens AT, Bundgaard H, Benson L, Mestroni L, Taylor MRG, Patel AR, Wilmot I, Thrush P, Soslow JH, Becker JR, Seidman CE, Ho CY. Transforming Growth Factor-? Analysis of the VANISH Trial Cohort. Circ Heart Fail. 2023 04; 16(4):e010314.
-
Lynch A, Tatangelo M, Ahuja S, Steve Fan CP, Min S, Lafreniere-Roula M, Papaz T, Zhou V, Armstrong K, Aziz PF, Benson LN, Butts R, Dragulescu A, Gardin L, Godown J, Jeewa A, Kantor PF, Kaufman BD, Lal AK, Parent JJ, Richmond M, Russell MW, Balaji S, Stephenson EA, Villa C, Jefferies JL, Whitehill R, Conway J, Howard TS, Nakano SJ, Rossano J, Weintraub RG, Mital S. Risk of Sudden Death in Patients?With?RASopathy Hypertrophic?Cardiomyopathy. J Am Coll Cardiol. 2023 03 21; 81(11):1035-1045.
-
Sucharov CC, Neltner B, Pietra AE, Karimpour-Fard A, Patel J, Ho CY, Miyamoto SD. Circulating MicroRNAs Identify Early Phenotypic Changes in Sarcomeric Hypertrophic Cardiomyopathy. Circ Heart Fail. 2023 06; 16(6):e010291.
-
Conway J, Min S, Villa C, Weintraub RG, Nakano S, Godown J, Tatangelo M, Armstrong K, Richmond M, Kaufman B, Lal AK, Balaji S, Power A, Baez Hernandez N, Gardin L, Kantor PF, Parent JJ, Aziz PF, Jefferies JL, Dragulescu A, Jeewa A, Benson L, Russell MW, Whitehill R, Rossano J, Howard T, Mital S. The Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy. Circulation. 2023 02 28; 147(9):718-727.
-
Axelsson Raja A, Wakimoto H, DeLaughter DM, Reichart D, Gorham J, Conner DA, Lun M, Probst CK, Sakai N, Knipe RS, Montesi SB, Shea B, Adam LP, Leinwand LA, Wan W, Choi ES, Lindberg EL, Patone G, Noseda M, H?bner N, Seidman CE, Tager AM, Seidman JG, Ho CY. Ablation of lysophosphatidic acid receptor 1 attenuates hypertrophic cardiomyopathy in a mouse model. Proc Natl Acad Sci U S A. 2022 07 12; 119(28):e2204174119.
-
Bolin EH, Spray BJ, Mourani PM, Porter C, Collins RT. Mortality among infants of diabetic mothers with hypertrophic cardiomyopathy. J Matern Fetal Neonatal Med. 2022 Dec; 35(25):9893-9899.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|